Connecting and Innovating for Better Health

We come from many disciplines and backgrounds, united by a vision of a world where better information empowers people to end disease and realize true health.

Building tools and infrastructure, creating care models, and sharing and enabling research are the ways our dedicated investigators and staff express commitment to improving patients’ lives. Their stories fuel our pursuit of the best possible health care for all people. Learn more about how you can join us in revolutionizing care.

Explore our work

Regenstrief Public License

Latest News

January 22, 2020 • News
Scientists isolate biomarkers that can identify delirium risk and severity
Scientists isolate biomarkers that can identify delirium risk and severity
Opens door to easy, early identification of individuals at risk for delirium complications Regenstrief Institute and Indiana University School of Medicine researchers have identified blood-based biomarkers associated with both delirium duration and severity in critically ill patients. This finding opens the door to easy, early identification of individuals at risk for longer delirium duration and […]
Continue Reading >
January 17, 2020 • News
Putting the “Why” in “EHR”: Expert on clinical information systems presents Regenstrief SAM Talk
Regenstrief Institute welcomed informatics expert James Cimino, M.D., for its January SAM (Scientists Advancing Medicine) Talk, presented in collaboration with the Indiana University School of Informatics and Computing at IUPUI Colloquia Series. Dr. Cimino has been a clinician, an informaticist, a systems architect and an educator for more than 30 years. His specialty is clinical […]
Continue Reading >
January 15, 2020 • News
First randomized clinical trial found no harms from dementia screening in primary care
First randomized clinical trial found no harms from dementia screening in primary care
Dementia screening did not induce depression or anxiety in older adults Research scientists at Regenstrief Institute and Indiana University School of Medicine have conducted the first randomized controlled trial to evaluate the pros and cons of population screening for dementia. The researchers found no harm, as measured by patient reported depressive and anxiety symptoms, from […]
Continue Reading >
More News